-
1
-
-
85026151773
-
Cancer facts & figures 2010.
-
Atlanta (GA), American Cancer Society
-
American Cancer Society. Cancer facts & figures 2010. Atlanta (GA): American Cancer Society; 2010; p. 1-62.
-
(2010)
, pp. 1-62
-
-
-
2
-
-
77955549719
-
The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
-
Bristow RE, Palis BE, Chi DS, Cliby WA. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol 2010;118:262-7.
-
(2010)
Gynecol Oncol
, vol.118
, pp. 262-7
-
-
Bristow, R.E.1
Palis, B.E.2
Chi, D.S.3
Cliby, W.A.4
-
3
-
-
32144437596
-
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
-
Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 2006;98:172-80.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 172-80
-
-
Earle, C.C.1
Schrag, D.2
Neville, B.A.3
Yabroff, K.R.4
Topor, M.5
Fahey, A.6
-
4
-
-
27144439275
-
Who should operate on patients with ovarian cancer? An evidence-based review.
-
Giede KC, Kieser K, Dodge J, Rosen B. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol 2005;99:447-61.
-
(2005)
Gynecol Oncol
, vol.99
, pp. 447-61
-
-
Giede, K.C.1
Kieser, K.2
Dodge, J.3
Rosen, B.4
-
5
-
-
77949285384
-
Quality of care in advanced ovarian cancer: the importance of provider specialty.
-
Mercado C, Zingmond D, Karlan BY, Sekaris E, Gross J, Maggard-Gibbons M, et al. Quality of care in advanced ovarian cancer: the importance of provider specialty. Gynecol Oncol 2010;117:18-22.
-
(2010)
Gynecol Oncol
, vol.117
, pp. 18-22
-
-
Mercado, C.1
Zingmond, D.2
Karlan, B.Y.3
Sekaris, E.4
Gross, J.5
Maggard-Gibbons, M.6
-
6
-
-
34248398805
-
The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review.
-
Vernooij F, Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 2007;105:801-12.
-
(2007)
Gynecol Oncol
, vol.105
, pp. 801-12
-
-
Vernooij, F.1
Heintz, P.2
Witteveen, E.3
van der Graaf, Y.4
-
7
-
-
0034268483
-
Guidelines for referral to a gynecologic oncologist: rationale and benefits. The Society of Gynecologic Oncologists.
-
Guidelines for referral to a gynecologic oncologist: rationale and benefits. The Society of Gynecologic Oncologists. Gynecol Oncol 2000;78:S1-13.
-
(2000)
Gynecol Oncol
, vol.78
-
-
-
8
-
-
0036884015
-
The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. ACOG Committee Opinion No. 280. American College of Obstetricians and Gynecologists.
-
The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. ACOG Committee Opinion No. 280. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:1413-6.
-
(2002)
Obstet Gynecol
, vol.100
, pp. 1413-6
-
-
-
9
-
-
31544431784
-
Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
-
Engelen MJ, Kos HE, Willemse PH, Aalders JG, de Vries EG, Schaapveld M, et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 2006 Feb 1;106:589-98.
-
Cancer 2 Feb
, vol.106
, pp. 589-98
-
-
Engelen, M.J.1
Kos, H.E.2
Willemse, P.H.3
Aalders, J.G.4
de Vries, E.G.5
Schaapveld, M.6
-
10
-
-
34248374708
-
Predictors of comprehensive surgical treatment in patients with ovarian cancer.
-
Goff BA, Matthews BJ, Larson EH, Andrilla CH, Wynn M, Lishner DM, et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer 2007;109:2031-42.
-
(2007)
Cancer
, vol.109
, pp. 2031-42
-
-
Goff, B.A.1
Matthews, B.J.2
Larson, E.H.3
Andrilla, C.H.4
Wynn, M.5
Lishner, D.M.6
-
11
-
-
33645328575
-
Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals.
-
Paulsen T, Kjaerheim K, Kaern J, Tretli S, Trope C. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer 2006;16(suppl 1):11-7.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 11-7
-
-
Paulsen, T.1
Kjaerheim, K.2
Kaern, J.3
Tretli, S.4
Trope, C.5
-
12
-
-
60449102223
-
Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands.
-
Vernooij F, Heintz AP, Coebergh JW, Massuger LF, Witteveen PO, van der Graaf Y. Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol 2009;112:455-61.
-
(2009)
Gynecol Oncol
, vol.112
, pp. 455-61
-
-
Vernooij, F.1
Heintz, A.P.2
Coebergh, J.W.3
Massuger, L.F.4
Witteveen, P.O.5
van der Graaf, Y.6
-
13
-
-
38649134531
-
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
-
Moore RG, Brown AK, Miller MC, Skates S, Allard WJ, Verch T, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol 2008;108:402-8.
-
(2008)
Gynecol Oncol
, vol.108
, pp. 402-8
-
-
Moore, R.G.1
Brown, A.K.2
Miller, M.C.3
Skates, S.4
Allard, W.J.5
Verch, T.6
-
14
-
-
57649088474
-
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
-
Moore RG, McMeekin DS, Brown AK, Disilvestro P, Miller MC, Allard WJ, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol 2009;112:40-6.
-
(2009)
Gynecol Oncol
, vol.112
, pp. 40-6
-
-
Moore, R.G.1
McMeekin, D.S.2
Brown, A.K.3
Disilvestro, P.4
Miller, M.C.5
Allard, W.J.6
-
15
-
-
77956342398
-
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.
-
Moore RG, Jabre-Raughley M, Brown AK, Robison KM, Miller MC, Allard WJ, et al. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol 2010;203:228.e1-6.
-
(2010)
Am J Obstet Gynecol
, vol.203
, pp. e1-e6
-
-
Moore, R.G.1
Jabre-Raughley, M.2
Brown, A.K.3
Robison, K.M.4
Miller, M.C.5
Allard, W.J.6
-
16
-
-
47249163215
-
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
-
Moore RG, Brown AK, Miller MC, Badgwell D, Lu Z, Allard WJ, et al. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecol Oncol 2008;110:196-201.
-
(2008)
Gynecol Oncol
, vol.110
, pp. 196-201
-
-
Moore, R.G.1
Brown, A.K.2
Miller, M.C.3
Badgwell, D.4
Lu, Z.5
Allard, W.J.6
-
17
-
-
16844374909
-
Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
-
Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 2005;65:2162-9.
-
(2005)
Cancer Res
, vol.65
, pp. 2162-9
-
-
Drapkin, R.1
von Horsten, H.H.2
Lin, Y.3
Mok, S.C.4
Crum, C.P.5
Welch, W.R.6
-
18
-
-
33646886778
-
Comprehensive analysis of HE4 expression in normal and malignant human tissues.
-
Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol 2006;19:847-53.
-
(2006)
Mod Pathol
, vol.19
, pp. 847-53
-
-
Galgano, M.T.1
Hampton, G.M.2
Frierson, H.F.3
-
19
-
-
0033693082
-
Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.
-
Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000;60:6281-7.
-
(2000)
Cancer Res
, vol.60
, pp. 6281-7
-
-
Hough, C.D.1
Sherman-Baust, C.A.2
Pizer, E.S.3
Montz, F.J.4
Im, D.D.5
Rosenshein, N.B.6
-
20
-
-
0035970050
-
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
-
Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A 2001;98:1176-81.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 1176-81
-
-
Welsh, J.B.1
Zarrinkar, P.P.2
Sapinoso, L.M.3
Kern, S.G.4
Behling, C.A.5
Monk, B.J.6
-
21
-
-
0038756386
-
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
-
Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 2003;63:3695-700.
-
(2003)
Cancer Res
, vol.63
, pp. 3695-700
-
-
Hellstrom, I.1
Raycraft, J.2
Hayden-Ledbetter, M.3
Ledbetter, J.A.4
Schummer, M.5
McIntosh, M.6
-
22
-
-
64949192073
-
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts.
-
Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, et al. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer 2009;100:1315-9.
-
(2009)
Br J Cancer
, vol.100
, pp. 1315-9
-
-
Huhtinen, K.1
Suvitie, P.2
Hiissa, J.3
Junnila, J.4
Huvila, J.5
Kujari, H.6
-
23
-
-
77951976918
-
Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.
-
Nolen B, Velikokhatnaya L, Marrangoni A, De GK, Lomakin A, Bast RC Jr, et al. Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecol Oncol 2010;117:440-5.
-
(2010)
Gynecol Oncol
, vol.117
, pp. 440-5
-
-
Nolen, B.1
Velikokhatnaya, L.2
Marrangoni, A.3
De, G.K.4
Lomakin, A.5
Bast, R.C.6
-
24
-
-
0020559574
-
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
-
Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309:883-7.
-
(1983)
N Engl J Med
, vol.309
, pp. 883-7
-
-
Bast, R.C.1
Klug, T.L.2
St John, E.3
Jenison, E.4
Niloff, J.M.5
Lazarus, H.6
-
25
-
-
0027521696
-
Elevation of multiple serum markers in patients with stage I ovarian cancer.
-
Woolas RP, Xu FJ, Jacobs IJ, Yu YH, Daly L, Berchuck A, et al. Elevation of multiple serum markers in patients with stage I ovarian cancer. J Natl Cancer Inst 1993;85:1748-51.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1748-51
-
-
Woolas, R.P.1
Xu, F.J.2
Jacobs, I.J.3
Yu, Y.H.4
Daly, L.5
Berchuck, A.6
-
26
-
-
79952784426
-
The ROMA (The Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
-
Montagnana M, Danese E, Ruzzenente O, Bresciani V, Nuzzo T, Gelati M, et al. The ROMA (The Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful? Clin Chem Lab Med 2011;49:521-5.
-
(2011)
Clin Chem Lab Med
, vol.49
, pp. 521-5
-
-
Montagnana, M.1
Danese, E.2
Ruzzenente, O.3
Bresciani, V.4
Nuzzo, T.5
Gelati, M.6
-
27
-
-
79952801158
-
Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.
-
Kim YM, Whang DH, Park J, Kim SH, Lee SW, Park HA, et al. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population. Clin Chem Lab Med 2011;49:527-34.
-
(2011)
Clin Chem Lab Med
, vol.49
, pp. 527-34
-
-
Kim, Y.M.1
Whang, D.H.2
Park, J.3
Kim, S.H.4
Lee, S.W.5
Park, H.A.6
|